Skip to main content
Clinical Trials/NCT01881178
NCT01881178
Completed
Not Applicable

The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein (NOPALEA)

Mark Mattie1 site in 1 country287 target enrollmentMay 2013
ConditionsInflammation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammation
Sponsor
Mark Mattie
Enrollment
287
Locations
1
Primary Endpoint
HS-CRP
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This study has been developed to investigate the anti-inflammatory effects of a commercial product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research method employs a double blind, placebo controlled, and time-series (repeat measures) design with high-sensitivity C-Reactive Protein (HS-CRP) serving as a marker for inflammation - testing for levels of CRP at time points: baseline (pre-test), 8 weeks (60 days) and 12 weeks (90 days). The final time point (i.e., 12 weeks) will serve as the post-test. It is expected that baseline CRP levels in healthy participants will decline.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
March 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Mark Mattie
Responsible Party
Sponsor Investigator
Principal Investigator

Mark Mattie

Associate Professor

University of Bridgeport

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

HS-CRP

Time Frame: 12 weeks

Study Sites (1)

Loading locations...

Similar Trials